drugset / Trial / NCT03233633
Marijuana in Combination With Opioids in Palliative and Hospice Patients
NaSingle-groupOpen-labelSupportive care
Summary
Study Objectives: Primary reduction of pain and reduction in overall opioid utilization. Secondary improvement in overall patient well being, weight stabilization with increased appetite, improved oxygen saturation, improvement or prevention of nausea and vomiting. Study Rationale: To determine optimum use and dosing of medical marijuana (CBD:THC) for pain and symptom management. Study Population: This study specifically will enroll cancer and non-cancer patients as a primary diagnosis suffering from pain and having a terminal illness (defined as having less than 6 months to live) requiring end of life care.
Timeline
- Start
- 2017-05-10
- Primary completion
- 2022-08-05
- Completion
- 2022-08-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | — | Oral |
Indications
No indication recorded.